Established in the year 2009 in India, Aarambh Life Science is one of the newer players in the Pharmaceutical industry. The company started off with the mission to make a difference by fulfilling the specialized needs in the Global Pharmaceutical Field.

Initially, Aarambh started out with the production of VETERINARY API and eventually extended its operations to HUMAN API.

Aarambh group consists of Five Manufacturing units. Each located at the best of locations in India – Gujarat and Andhra Pradesh, which are Pharma Manufacturing hub of India.

For Aarambh, each stakeholder is a concern. More than products, the trust and service that it gives, is what makes it a reliable source in the competitive environment.

Today, the company’s product portfolio includes API for animals in the areas such as anthelmintic, anti-parasitic, anti-infective, anti-amoebic, anti-protozon, anti-inflammatory, anesthetic and others. Additionally, the company also provides Human API in the areas of anti-diabetics, anti-hypertension, anti-inflammatory, anti-depressant, anthelmintic, iron supplements and others.

The company has a world class Unit with GMP facility. These facilities have always tried and shall always will work without harming the environment and the people around.

With Anti-malarial APIs being introduced, the company is now looking forward and is about to implement its production of Veterinary Formulations & Human Formulations.

With opportunities in this segment abroad, Aarambh Life Science has moved across the border to provide healthcare solutions in countries such as Brazil, Mexico, France, Germany, China, Australia to name a few.

We continue to remain committed not only by fulfilling specialized needs in the Global Pharmaceutical field, but also create an environment of integrity to provide value to our customers, employees, vendors & society at large and help each stakeholder grow with mutual respect and consideration. The aspiration on which the group was founded have always inspired growth and will continue to do so in times to come.